Publication list
2024
Várvölgyi, T.,
Janka, E.,
Szász, I.,
Koroknai, V.,
Toka-Farkas, T.,
Szabó, I.,
Ványai, B.,
Szegedi, A.,
Emri, G.,
Balázs, M.:
Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
J Clin Med. 13 (1), 1-13, 2024.
Journal metrics:
Q1 Medicine (miscellaneous) (2023)
Janka, E.,
Szabó, I.,
Kollár, S.,
Toka-Farkas, T.,
Ványai, B.,
Várvölgyi, T.,
Kapitány, A.,
Shabu, H.,
Szegedi, A.,
Emri, G.:
Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors.
Cancers (Basel). 16 1-18, 2024.
Journal metrics:
Q2 Cancer Research (2023)
Q1 Oncology (2023)
2023
Ványai, B.,
Szabó, I.,
Veres, I.,
Soltész, L.,
Várvölgyi, T.,
Emri, G.:
Lentigo maligna melanoma.
Bőrgyógyász. venerol. szle. 99 (4), 293-297, 2023.
Janka, E.,
Ványai, B.,
Szabó, I.,
Toka-Farkas, T.,
Várvölgyi, T.,
Kapitány, A.,
Szegedi, A.,
Emri, G.:
Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
Front Oncol. 13 1-11, 2023.
Journal metrics:
Q2 Cancer Research
Q2 Oncology
2022
Ványai, B.,
Chien, Y.,
Beke, L.,
Szabó, I.,
Péter, Z.,
Steuer-Hajdu, K.,
Várvölgyi, T.,
Méhes, G.,
Emri, G.:
Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanoma.
Immunotherapy. 14 (17), 1377-1382, 2022.
Journal metrics:
Q3 Immunology
Q2 Immunology and Allergy
Q2 Oncology
Csató, G.,
Erdei, N.,
Ványai, B.,
Balla, T.,
Czuriga, D.,
Csanádi, Z.,
Kőszegi, Z.,
Édes, I.,
Szabó, G.:
Predictors of restenosis following percutaneous coronary stent implantation: the role of trimetazidine therapy.
Front. Cardiovasc. Med. 9 1-9, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Janka, E.,
Ványai, B.,
Dajnoki, Z.,
Szabó, I.,
Reibl, D.,
Komka, I.,
Blasszauer, C.,
Várvölgyi, T.,
Szegedi, A.,
Emri, G.:
Regional variability of melanoma incidence and prevalence in Hungary. Epidemiological impact of ambient UV radiation and socioeconomic factors.
Eur. J. Cancer Prev. 31 (4), 377-384, 2022.
Journal metrics:
Q3 Cancer Research
Q3 Epidemiology
Q3 Oncology
Q2 Public Health, Environmental and Occupational Health
2021
2018
2017
updated: 2024-11-10, 02:13
